AMILORIDE HYDROCHLOROTHIAZIDE TEVA 5 mg/50 mg, tablet 30 tablets
Active ingredients: Amiloride hydrochloride, Amiloride hydrochloride, HYDROCHLOROTHIAZIDE
Commercialized according to BDPMDispensing in France: Prescription only
Tablet30 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- AMILORIDE HYDROCHLOROTHIAZIDE TEVA 5 mg/50 mg, comprimé
- Pharmaceutical form
- comprimé
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC PVDC aluminium de 30 comprimé(s)
- Marketing authorisation holder
- TEVA SANTE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 1 Oct 2003
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68045361CIP73519205CIP133400935192059Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| HYDROCHLOROTHIAZIDEcomprimé | 50 mg · un comprimé | SA |
| CHLORHYDRATE D'AMILORIDEcomprimé | 5,68 mg · un comprimé | SA |
| CHLORHYDRATE D'AMILORIDE ANHYDREcomprimé | 5 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The published catalog does not list other packages of similar medicines.